ABIONYX Pharma SA (ENXTPA: ABNX) has a market capitalization of $74.70M. Last close €1.63 (as of 2026-10-21); 52-week range €1.41 to €5.29. ORTEX data as of 2026-10-19: short interest is 0.25% of free float, 0.6 days to cover and the average cost to borrow is 266.92%.